- Type II DM:
- Conversion from sitagliptin plus metformin: 1 tab BD
- If on metformin 850mg BD, start 50mg/1000mg BD
- Max: 100mg/2000mg/day
- Conversion from sitagliptin plus metformin: 1 tab BD
-
- Conversion from sitagliptin: Initially 50mg/500mg BD
- Max: 100mg/2000mg/day
- Conversion from sitagliptin: Initially 50mg/500mg BD
-
- Conversion from metformin: Sitagliptin 50mg BD and current daily dose of metformin
- If on metformin 850mg BD, start 50mg/1000mg BD
- Max: 100 mg/2000 mg/day
- Conversion from metformin: Sitagliptin 50mg BD and current daily dose of metformin
- Tablet:
- 50/500mg
- 50/850mg
- 50/1000mg
To be given with meals
Sitagliptin: (DPP-4) inhibitor; It inhibits dipeptidyl peptidase-4, slowing incretin metabolism, increasing insulin synthesis/release thereby decreasing glucagon levels
Metformin: Biguanide; It delays the absorption of glucose from the GI tract and increase insulin sensitivity in the muscle thereby improving peripheral glucose uptake and utilization in cells.
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Abdominal discomfort
- Indigestion
- Vitamin B12 deficiency
- Asthenia
- Headache
- URI
- Rash
- Arthralgia
- Anorexia
- Metallic taste
- Ovulation induction
- Hypersensitivity to class/components
- eGFR <30
- eGFR 30-45 (tx initiation use)
- Type I DM
- Metabolic acidosis
- Lactic acidosis
- Hypoxemia
- Dehydration
- Sepsis
- Surgery
- Hepatic disease
WARNING:
Lactic acidosis: post-marketing cases of hypothermia, hypotension, resistant bradyarrhythmias and death reported. If suspected, discontinue and hospitalize the patient immediately
- Cidofovir
Drug Status
Availability | Prescription only |
Pregnancy | Category B; weigh risk vs benefit |
Breastfeeding | Not recommended |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Dygli-M | 50mg/1g | Tablet | 30’s | Prisma Pharma | Wessex Pharma |
Esglip-M | 50mg/500mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
Esglip-M | 50mg/1g | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
Esglip-M | 50mg/850mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
Glipita M | 50mg/1g | Tablet | 30’s | Beximco Pharma | Madawa Pharma |
Glipita M | 50mg/500mg | Tablet | 30’s | Beximco Pharma | Madawa Pharma |
Glipmevia | 50mg/1g | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
Glipmevia | 50mg/500mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
Glipmevia | 50mg/850mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
Glipmevia | 50mg/500mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
Glipmevia | 50mg/850mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
Glipmevia | 50mg/1000mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
Glucoglip | 50mg/500mg | Tablet | 100’s | Biodeal Labs | Biodeal Labs |
Inosita Plus | 50mg/500mg | Tablet | 28’s | Pharmevo | Harley’s Ltd |
Inosita Plus | 50mg/1g | Tablet | 28’s | Pharmevo | Harley’s Ltd |
Janumet | 50mg/1g | Tablet | 56’s | MSD Ltd | Imperial Managed |
Janumet | 50mg/850mg | Tablet | 56’s | MSD Ltd | Imperial Managed |
Jentin Met | 50mg/1g | Tablet | 14’s | The Seale Company | Globe Pharmacy |
Jentin Met | 50mg/500mg | Tablet | 14’s | The Seale Company | Globe Pharmacy |
Qsita-M | 50mg/500mg | Tablet | 10’s | Q Pharma DMCC | Cintana Healthcare |
Sita-Met | 50mg/500mg | Tablet | 14’s | CCL Pharma | Harley’s Ltd |
Sita-Met | 50mg/1g | Tablet | 14’s | CCL Pharma | Harley’s Ltd |
Sitamet | 50mg/1g | Tablet | 14’s | The Acme Labs | Highridge Pharma |
Sitamet | 50mg/500mg | Tablet | 14’s | The Acme Labs | Highridge Pharma |
Sitavia M | 50mg/500mg | Tablet | 20’s | Zawadi Healthcare | Zawadi Healthcare |
Sitavia M Forte | 50mg/1g | Tablet | 20’s | Zawadi Healthcare | Zawadi Healthcare |
Treviamet | 50mg/500mg | Tablet | 14’s, 35’s | Getz Pharma | Surgipharm Ltd |
Treviamet | 50mg/1g | Tablet | 35’s | Getz Pharma | Surgipharm Ltd |
Treviamet | 50mg/850mg | Tablet | 14’s | Getz Pharma | Surgipharm Ltd |